Search
Jieshi Medical Secures Series B Funding
1 day ago /
Read about 0 minute
Author：小编
Shanghai Jieshi Medical Technology Co., Ltd. has recently announced the successful completion of its Series B funding round, led by Yunsheng Investment and supported by Xingliang Investment. The company, a specialist in ophthalmic medical devices, has developed the independently produced JieShi® perfluoropropane gas for ophthalmic applications, which has been approved for marketing. This innovative product is utilized within the vitreous cavity for treatment purposes, significantly enhancing retinal repositioning and healing processes. The newly secured funding will expedite the commercialization of this groundbreaking product and further propel the development of new technologies.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
